These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2234782)

  • 1. [Dialysability of cytostatic drugs. Experimental studies in vitro].
    Füger K; Blumenstein M; Sauer H
    Onkologie; 1990 Aug; 13(4):289-94. PubMed ID: 2234782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of cytotoxicity of cytostatic drugs by hemodialysis in vitro and in vivo.
    Sauer H; Füger K; Blumenstein M
    Cancer Treat Rev; 1990 Sep; 17(2-3):293-300. PubMed ID: 2272045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression by cytostatic drugs?
    Ulrichs K; Yu MY; Duncker D; Müller-Ruchholtz W
    Behring Inst Mitt; 1984 May; (74):239-49. PubMed ID: 6332617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.
    Gkotzamanidou M; Papadimitriou CA
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-schedule dependency of the inhibiting activity of various anticancer drugs in the clonogenic assay.
    Matsushima Y; Kanzawa F; Hoshi A; Shimizu E; Nomori H; Sasaki Y; Saijo N
    Cancer Chemother Pharmacol; 1985; 14(2):104-7. PubMed ID: 3971474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical screening for drugs effective against 5-fluorouracil-resistant cells with a murine L5178Y cell line in vitro.
    Hill BT
    J Natl Cancer Inst; 1983 Aug; 71(2):335-40. PubMed ID: 6576190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of individual sensitivity to cytostatic drugs of in vitro cultured lung tumor cells.
    Gebarowska E; Zabel M; Majewski A; Kołodziej J
    Folia Histochem Cytobiol; 1999; 37(2):135-6. PubMed ID: 10352995
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiproliferative potential of cytostatic drugs on neuroblastoma cells in vitro.
    Fulda S; Honer M; Menke-Moellers I; Berthold F
    Eur J Cancer; 1995; 31A(4):616-21. PubMed ID: 7576981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligonucleotides protect cells from the cytotoxicity of several anti-cancer chemotherapeutic drugs.
    Blagosklonny MV; Neckers LM
    Anticancer Drugs; 1994 Aug; 5(4):437-42. PubMed ID: 7949248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-resistance of vinblastine- and taxol-resistant mutants of Chinese hamster ovary cells to other anticancer drugs.
    Gupta RS
    Cancer Treat Rep; 1985 May; 69(5):515-21. PubMed ID: 2860971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination effects of etoposide with other antitumor drugs in vitro and in vivo].
    Nishikawa K; Kusama K; Ekimoto H; Takahashi K
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3739-45. PubMed ID: 2596858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle, melanin contents and apoptosis processes in B16 and Cloudman S91 mouse melanoma cells after exposure to cytostatic drugs.
    Olszewska-Słonina DM; Styczyński J; Czajkowski R; Drewa TA; Musiałkiewicz D
    Acta Pol Pharm; 2007; 64(5):469-78. PubMed ID: 18540169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The addition of ifosfamide/etoposide to cisplatin/teniposide improves the survival of children with retinoblastoma and orbital involvement.
    Antoneli CB; Ribeiro KB; Rodriguez-Galindo C; Soares FA; Arias VA; Novaes PE; Chojniak MM; Malogolowkin M
    J Pediatr Hematol Oncol; 2007 Oct; 29(10):700-4. PubMed ID: 17921851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of apoptosis and necrosis induction in cultured cells of lung carcinomas under effect of cytostatic drugs in vitro.
    Drag-Zalesińska M; Wysocka T; Gebarowska E; Zabel M
    Folia Histochem Cytobiol; 1999; 37(2):133-4. PubMed ID: 10352994
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical pharmacokinetics of commonly used anticancer drugs.
    Balis FM; Holcenberg JS; Bleyer WA
    Clin Pharmacokinet; 1983; 8(3):202-32. PubMed ID: 6189661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability and compatibility of antitumor agents in glass and plastic containers.
    Benvenuto JA; Anderson RW; Kerkof K; Smith RG; Loo TL
    Am J Hosp Pharm; 1981 Dec; 38(12):1914-8. PubMed ID: 7325172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic cytotoxicity of recombinant human TNF and various anti-cancer drugs.
    Watanabe N; Niitsu Y; Yamauchi N; Ohtsuka Y; Sone H; Neda H; Maeda M; Urushizaki I
    Immunopharmacol Immunotoxicol; 1988; 10(1):117-27. PubMed ID: 2452179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK-cell activity affected by some cytostatic drugs and their additives.
    Ujházy P; Babusíková O
    Neoplasma; 1991; 38(3):303-12. PubMed ID: 1857450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cytostatic drugs on nucleic acid synthesis in mouse thymocytes and chick embryo cells.
    Håkansson L
    Arzneimittelforschung; 1975 Mar; 25(3):378-82. PubMed ID: 1080422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of human adenocarcinomas of the colon and the stomach as regards sensitivity to cytostatic drugs.
    Tropé C; Håkansson L; Dencker H
    Neoplasma; 1975; 22(4):423-9. PubMed ID: 1196425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.